TrialBone marrow transplantation2016

A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy.

M Martino et al.PubMed ↗Publisher ↗

No numbers read from the abstract.